Sundararajan M, Rathinam SR, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, D Miller C, Lim LL, Suhler EB, Al-Dhibi HA et al..  2025.  Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease.. Ocul Immunol Inflamm. 33(2):263-270.

Acharya NR, Rathinam SR, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Gonzales JA, Lim LL, Suhler EB, Al-Dhibi HA et al..  2024.  Outcomes in Patients with Vogt-Koyanagi-Harada Disease from the First-line Antimetabolites for Steroid-sparing Treatment Uveitis Trial.. Am J Ophthalmol. 

Chattopadhyay A, Rathinam SR, Gonzales JA, Kelly NK, Thundikandy R, Kanakath A, S Murugan B, Vedhanayaki R, Lim LL, Suhler EB et al..  2023.  Association between Quality of Life and Visual Acuity in a Randomized Clinical Trial of Patients with Uveitis Taking Antimetabolites.. Ocul Immunol Inflamm. :1-9.

Tsui E, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA et al..  2022.  Outcomes of uveitic macular edema in the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial.. Ophthalmology. 

Bui AD, Kong CL, Kelly NK, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan B, Vedhanayaki R, Lim LL et al..  2022.  Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil.. Ophthalmology. 

Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, S Murugan B, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T et al..  2019.  Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.. JAMA. 322(10):936-945.